Ji Yao Holding Group Co., Ltd.

SZSE:300108 Stock Report

Market Cap: CN¥1.5b

Ji Yao Holding Group Past Earnings Performance

Past criteria checks 0/6

Ji Yao Holding Group has been growing earnings at an average annual rate of 34.8%, while the Pharmaceuticals industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 23.5% per year.

Key information

34.8%

Earnings growth rate

34.9%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate-23.5%
Return on equityn/a
Net Margin-120.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenues Not Telling The Story For Ji Yao Holding Group Co., Ltd. (SZSE:300108)

Oct 24
Revenues Not Telling The Story For Ji Yao Holding Group Co., Ltd. (SZSE:300108)

Ji Yao Holding Group Co., Ltd. (SZSE:300108) Not Doing Enough For Some Investors As Its Shares Slump 39%

Jul 01
Ji Yao Holding Group Co., Ltd. (SZSE:300108) Not Doing Enough For Some Investors As Its Shares Slump 39%

Revenue & Expenses Breakdown

How Ji Yao Holding Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300108 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24363-43624412
30 Jun 24354-39722313
31 Mar 24350-37021513
31 Dec 23346-34921213
30 Sep 23348-11216014
30 Jun 23396-12418316
31 Mar 23443-24425317
01 Jan 23489-27625918
30 Sep 22562-45328515
30 Jun 22588-46026814
31 Mar 22638-46932917
01 Jan 22685-45134117
30 Sep 21628-48837817
30 Jun 21673-52846618
31 Mar 21673-37433416
31 Dec 20649-38033616
30 Sep 20732-1,98373692
30 Jun 20813-1,88065189
31 Mar 20907-1,84166991
31 Dec 191,066-1,77265592
30 Sep 191,19612725617
30 Jun 191,11416221419
31 Mar 191,10521017517
31 Dec 1894221715515
30 Sep 187762038411
30 Jun 187712038516
31 Mar 187072057712
31 Dec 177002027910
30 Sep 177501801017
30 Jun 17767200960
31 Mar 17736189870
31 Dec 16747186830
30 Sep 16666119710
30 Jun 16632115690
31 Mar 16655132710
31 Dec 15678136720
30 Sep 15703146660
30 Jun 15616119640
31 Mar 1546785570
31 Dec 1434357510
30 Sep 1422340370
30 Jun 1417429350
31 Mar 1417628350
31 Dec 1316527320

Quality Earnings: 300108 is currently unprofitable.

Growing Profit Margin: 300108 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300108 is unprofitable, but has reduced losses over the past 5 years at a rate of 34.8% per year.

Accelerating Growth: Unable to compare 300108's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300108 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-2.5%).


Return on Equity

High ROE: 300108's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies